Call Options

28 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $7.82 Million - $9.51 Million
-47,700 Reduced 20.45%
185,500 $36.6 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $6.15 Million - $7.18 Million
-39,700 Reduced 14.55%
233,200 $40 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $63.9 Million - $72.8 Million
-399,900 Reduced 59.44%
272,900 $49.7 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $37.6 Million - $42.3 Million
273,000 Added 68.28%
672,800 $104 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $6.12 Million - $7.08 Million
45,800 Added 12.94%
399,800 $59.6 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $556,542 - $692,580
-4,200 Reduced 1.17%
354,000 $47.7 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $983,348 - $1.13 Million
-6,800 Reduced 1.86%
358,200 $57.1 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $11.2 Million - $13.4 Million
81,000 Added 28.52%
365,000 $59 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $35.1 Million - $40.2 Million
-261,400 Reduced 47.93%
284,000 $38.1 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $59.9 Million - $76.2 Million
-435,400 Reduced 44.39%
545,400 $83.5 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $274 Million - $340 Million
-2,076,700 Reduced 67.92%
980,800 $159 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $249 Million - $315 Million
2,314,500 Added 311.51%
3,057,500 $414 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $37.9 Million - $43.1 Million
356,600 Added 92.29%
743,000 $80.1 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $13.9 Million - $15.4 Million
-131,700 Reduced 25.42%
386,400 $43.5 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $47.7 Million - $52.5 Million
-465,972 Reduced 47.35%
518,100 $56.1 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $30.2 Million - $40.8 Million
-375,600 Reduced 27.62%
984,072 $105 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $3.44 Million - $4.04 Million
40,054 Added 3.04%
1,359,672 $119 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $29.8 Million - $39.8 Million
405,718 Added 44.39%
1,319,618 $130 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $44.2 Million - $67.1 Million
685,900 Added 300.83%
913,900 $69.6 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $4.53 Million - $5.67 Million
62,800 Added 38.01%
228,000 $20.2 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $22.9 Million - $27.5 Million
-363,700 Reduced 68.77%
165,200 $12.5 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $37.2 Million - $47.5 Million
-565,500 Reduced 51.67%
528,900 $38.5 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $6.52 Million - $7.67 Million
84,500 Added 8.37%
1,094,400 $88.2 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $38.7 Million - $47.8 Million
497,700 Added 97.17%
1,009,900 $93.1 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $471,223 - $523,852
-5,300 Reduced 1.02%
512,200 $48.4 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $39.3 Million - $46.5 Million
437,500 Added 546.88%
517,500 $47.9 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $4.48 Million - $4.91 Million
50,000 Added 166.67%
80,000 $7.74 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $2.1 Million - $2.68 Million
30,000
30,000 $2.67 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.